Developer docs
API playgroundTry for free, no card

Search company profiles

Haleon

Full company profile

uuid00009in

Namestring
Haleon
Legal namestring
Haleon plc
Websiteurl
haleon.com
Company typeenum
Public
Founded yearint
2022
Descriptiontext

Haleon is a pure-play consumer health company created in July 2022 as a standalone listed entity following its demerger from GlaxoSmithKline, with a premium listing on the London Stock Exchange and a NYSE listing (HLN) via sponsored ADRs. It is headquartered in Weybridge, UK, employs 10,000+ people, and sells branded over-the-counter medicines, oral care products, vitamins/minerals/supplements and therapeutic skin health products across more than 170 markets organised into five regions. Its portfolio spans six global categories - Oral Health, Vitamins, Minerals and Supplements, Pain Relief, Respiratory, Digestive Health and other, and Therapeutic Skin Health - built around nine Power Brands (Sensodyne, parodontax, Polident, Centrum, Emergen-C, Caltrate, Otrivin, Theraflu, Flonase, Robitussin, Voltaren, Panadol, Advil, Excedrin, Tums, Eno, Fenistil, Zovirax and Bactroban) plus local growth brands, and reaches 1.4 billion consumers with an ambition to reach one billion more by 2030.

The technical base is a consumer-health R&D and regulatory platform rather than a software platform: decades of testing, clinical trials and real-world-evidence studies, world-class regulatory and product-licence expertise, a new c.£200m R&D facility, and 127 product innovations reported in 2024. Haleon claims leadership in therapeutic oral health, backed by brands such as Sensodyne, parodontax and Polident, and it uses clinical evidence as a marketing asset - the 2026 Nature Medicine publication based on the COSMOS trial showing Centrum Silver may slow biological ageing in older adults. Product innovation in 2026 included Excedrin Rapid Relief (relief in as little as 15 minutes), the Centrum Age Defy multivitamin for adults 35+, Panacombo dual-action tablets and the Sensodyne Clinical Repair line. On the technology side Haleon is deploying AI agents feeding a "clean core" SAP operating model across machine, energy, supply chain and customer-experience data, and it has added AI/ML-adjacent commercial analytics around algorithms, loyalty and execution; there is no public developer API or partner-facing model access.

Revenue is generated from one-time branded product sales through retail, pharmacy, wholesale and digital channels rather than recurring subscriptions; pricing is not publicly disclosed. Route-to-market is built around direct relationships with pharmacists, shopper-experience tools, in-store category-growth execution programmes and pharmacist education, supported by an extensive field sales force, with mass-retail shelf placement (Walmart, Target) contested against Procter & Gamble and Colgate-Palmolive. The company operates 25 manufacturing sites (24 certified to the Alliance for Water Stewardship Standard), reports 100% satisfactory health authority inspections in 2025, and targets £800m of gross cost savings over five years from its standalone supply chain. FY2025 revenue was £11bn; H1 2026 revenue was £5.6bn with non-GAAP EPS of 10.30p and FY 2026 guidance reaffirmed, against a stated financial algorithm of 4-6% annual organic revenue growth with high-single-digit adjusted operating profit growth at constant currency in a c.£200bn consumer healthcare market.

Short descriptiontext

Haleon is a pure-play consumer health company selling over-the-counter medicines, oral care, supplements and skin health brands such as Sensodyne, Advil, Centrum and Voltaren to consumers across more than 170 markets, through pharmacy, retail, wholesale and digital channels.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
10,001+
akta.pro rankint
HeadquartersLondon, United Kingdom
HQ citystring
London
HQ countrystring
United Kingdom
HQ regionstring
Europe
Markets served

Serves global market

Offices31 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
over-the-counter medicines, consumer health brands, oral care products, self-care health products, vitamins and supplements
Industry5 codes
PRIMARYCRADAMAD
Cold, Flu, Cough & Allergy Remedies (Decongestants, Antihistamines, Cough Syrups, Lozenges)
Consumer Products & Retail/Consumer Packaged Goods (CPG) Manufacturing & Brands/Health & Hygiene OTC Consumer Goods (First Aid, Oral Care, Personal Health)
SECONDARYCRADAMAF
Dermatology OTC & Skin Health (Acne Treatments, Eczema/Psoriasis OTC, Antifungals, Wart Removal)
Consumer Products & Retail/Consumer Packaged Goods (CPG) Manufacturing & Brands/Health & Hygiene OTC Consumer Goods (First Aid, Oral Care, Personal Health)
SECONDARYCRADAMAE
Digestive Health OTC (Antacids, Laxatives, Anti-diarrheals, Probiotics OTC)
Consumer Products & Retail/Consumer Packaged Goods (CPG) Manufacturing & Brands/Health & Hygiene OTC Consumer Goods (First Aid, Oral Care, Personal Health)
SECONDARYCRADAMAG
Eye, Ear & Nasal Care OTC (Eye Drops, Ear Drops/Wax Removal, Saline Sprays)
Consumer Products & Retail/Consumer Packaged Goods (CPG) Manufacturing & Brands/Health & Hygiene OTC Consumer Goods (First Aid, Oral Care, Personal Health)
SECONDARYCRADAMAJ
Sleep, Stress & Mood OTC (Sleep Aids, Melatonin OTC, Calm/Stress Relief)
Consumer Products & Retail/Consumer Packaged Goods (CPG) Manufacturing & Brands/Health & Hygiene OTC Consumer Goods (First Aid, Oral Care, Personal Health)
NAICS code3 codes
  • Drugs and Druggists' Sundries Merchant Wholesalers42421
  • Drugs and Druggists' Sundries Merchant Wholesalers4242
  • Drugs and Druggists' Sundries Merchant Wholesalers424210
SIC code1 code
  • Pharmaceutical Preparations2834
Product category
Consumer Health / Over-the-Counter Medicines and Personal Care Products
GTM motion4 records

Each record includes

Type, Description, Source

Revenue model2 records
1Branded consumer health product sales (Oral Health, VMS, Pain Relief, Respiratory, Digestive Health, Therapeutic Skin Health)
TypeHardware Sales
Description

One-time sales of over-the-counter medicines, oral care products, vitamins/minerals/supplements and therapeutic skin health products through retail, pharmacy and other channels across 170+ markets. This is the core revenue engine (FY2025 revenue £11bn; H1 2026 revenue £5.6bn), driven by category leadership, brand recommendation by health professionals and innovation-led premiumisation rather than recurring subscription revenue.

haleon.com
2Distribution and route-to-market wholesale (including new rural distribution build-out)
TypeTransaction Fee
Description

Revenue generated through selling branded products into wholesalers, pharmacy chains and mass retail, with expanded rural distribution in India (part of the £175m India investment) increasing access and volume throughput of oral health products.

haleon.com
Marketing channels9 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels5 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Supply Chain, Operations, Marketing or Sales, Technology or R&D, Personnel, Infrastructure
GTM typeB2C
B2C
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Brand1 of 23 records shown
1Sensodyne
Description

Oral health brand (toothpaste) for sensitive teeth; a leading Power Brand.

haleon.com
+22 more records
Core offering1 text field

Haleon manufactures and sells branded over-the-counter (OTC) medicines and consumer health products across six categories: Oral Health, Vitamins, Minerals and Supplements, Pain Relief, Respiratory, Digestive Health and other, and Therapeutic Skin Health. The portfolio is built around nine global Power Brands (Sensodyne, parodontax, Polident, Centrum, Emergen-C, Caltrate, Otrivin, Theraflu, Flonase, Voltaren, Panadol, Advil) plus local growth brands, sold through retail, pharmacy and wholesale channels in more than 170 markets. Haleon also operates the Haleon Health Partner digital portal for health professionals, an innovation portal and a supplier portal. FY2025 revenue was £11bn.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 9 values shown
  • 74 million+ people empowered to be more included in opportunities for better everyday health in the 2025 reporting period (1 Dec 2024-30 Nov 2025), surpassing the goal set in 2022
+8 more records
Product overview1 text field

Haleon is a pure-play consumer health company selling a portfolio of over-the-counter brands rather than a single software platform: it groups brands into six categories (Oral Health; Vitamins, Minerals and Supplements; Pain Relief; Respiratory; Digestive Health and other; Therapeutic Skin Health) built around nine Power Brands plus local growth brands. The Oral Health cluster is led by Sensodyne (sensitivity toothpaste/mouthwash), parodontax (gum health) and Polident (denture care), supported by Aquafresh, Biotene and Corsodyl; the VMS cluster by Centrum (multivitamins/minerals, e.g. Centrum Age Defy), Caltrate (calcium) and Emergen-C (vitamin C); Pain Relief by Panadol, Advil, Fenbid, Voltaren, Excedrin, Contac and Grand-pa; Respiratory by Otrivin, Theraflu, Flonase and Robitussin; Digestive Health by Tums, Eno, Benefiber and Alli; and Therapeutic Skin Health by Fenistil, Zovirax, Bactroban, Zovirax Duo and Chapstick/Abreva. Alongside these physical consumer brands Haleon operates related digital services and platforms, including the Haleon Health Partner portal for health professionals, an Innovation Portal, a Supplier Portal, investor Share Price Tools, the haleon.help consumer relations and adverse-event reporting service, and a Safety Data Sheets portal.

Product and service28 records
1Sensodyne
CategoryOral Health
Description

Specialist sensitivity toothpaste and mouthwash brand positioned at the forefront of Haleon's therapeutic oral health category, including Sensodyne Repair and Clinical Repair variants and mouthwash line extensions.

2parodontax
CategoryOral Health
Description

Therapeutic gum-health toothpaste and mouthwash brand (parodontax Active Gum Health) being expanded in China with local flavours to meet rising gum-health demand.

3Polident
CategoryOral Health
Description

Brand of daily dental appliance cleaners for denture care, including overnight whitening tablet formats, within Haleon's oral health portfolio.

4Aquafresh
CategoryOral Health
Description

Oral care brand (toothpaste, toothbrushes including the 1998 flex neck brush) within Haleon's oral health portfolio.

5Biotene
CategoryOral Health
Description

Oral care brand acquired in 2008, including moisturising mouthwash for dry mouth.

6Corsodyl
CategoryOral Health
Description

Oral care brand launched as a gel and mouthwash in 1975, acquired by SmithKline Beecham in 1993.

7Centrum
CategoryVitamins, Minerals and Supplements
Description

Category-leading multivitamin and mineral brand available in more than 70 markets, with variants such as Centrum MEN Multi-Gummies and the Centrum Age Defy multivitamin for adults 35+.

8Emergen-C
CategoryVitamins, Minerals and Supplements
Description

Vitamin C immune support brand in crystals and effervescent formulations, extended through a 'Drink of the Summer' campaign and mocktail collaboration with Carl Radke's Soft Bar.

9Caltrate
CategoryVitamins, Minerals and Supplements
Description

Leading calcium supplement brand within Haleon's vitamins, minerals and supplements category, now with double vitamin D3 formulations.

10Otrivin
CategoryRespiratory
Description

Nasal decongestant brand used to clear blocked noses, part of Haleon's cold and flu, decongestant and allergy portfolio.

11Theraflu
CategoryRespiratory
Description

Multi-symptom cold and flu treatment brand addressing fever, nasal congestion and cough (e.g. Theraflu Flu Relief Max Strength).

12Flonase
CategoryRespiratory
Description

Nasal allergy relief spray brand (Flonase Sensimist Allergy Relief Spray) in Haleon's respiratory health category.

13Robitussin
CategoryRespiratory
Description

Cough remedy brand including long-acting cough soft chews, within Haleon's leading respiratory portfolio.

14Voltaren
CategoryPain Relief
Description

Topical anti-inflammatory gel and arthritis pain gel brand (e.g. Voltaren Sport gel, Arthritis Pain Gel) used in sports, golf and UEFA Champions League licensed campaigns.

15Panadol
CategoryPain Relief
Description

World-leading paracetamol-based pain relief brand (Panadol Advance 500mg) serving as a global flagship of Haleon's pain relief portfolio.

16Advil
CategoryPain Relief
Description

Ibuprofen pain relief brand including liquid gels and minis formats, originating from the 1984 launch and now a core global Haleon brand.

17Fenbid
CategoryPain Relief
Description

Ibuprofen pain relief brand also sold in chewable format, launched in 1983 (as Solpaflex in some markets).

18Contac
CategoryPain Relief
Description

Pain and cold remedy brand in Haleon's pain relief portfolio.

19Grand-pa
CategoryPain Relief
Description

Headache powder brand sold in stick-pack formats within Haleon's pain relief range.

20Excedrin
CategoryPain Relief
Description

Headache relief brand (Excedrin Extra Strength) now marketed with a Rapid Relief claim of relief in as little as 15 minutes and a digital pet experience campaign.

21Tums
CategoryDigestive Health and other
Description

Antacid brand with chewy bites and tablet formats for heartburn and acid indigestion.

22Eno
CategoryDigestive Health and other
Description

Antacid brand (Eno Blue) with heritage in treating heartburn, acid indigestion and gastric discomfort.

23Benefiber
CategoryDigestive Health and other
Description

Prebiotic fibre supplement brand sold in gummy format within Haleon's digestive health portfolio.

24Fenistil
CategoryTherapeutic Skin Health
Description

Soothing antihistamine brand (including drops) for skin allergy conditions in Haleon's therapeutic skin health category.

25Zovirax
CategoryTherapeutic Skin Health
Description

Cold sore cream brand with duo and single-tube variants for cold sore treatment.

26Bactroban
CategoryTherapeutic Skin Health
Description

Topical antibiotic ointment brand for bacterial skin infections.

27Abreva
CategoryTherapeutic Skin Health
Description

Cold sore treatment brand in Haleon's therapeutic skin health category.

28Haleon Health Partner portal
CategoryHealth professional engagement platform
Description

Digital portal for health professionals providing clinical and consumer education resources to support recommendation of Haleon brands; it grew to 39 markets and supported over 52 million individuals in the 2025 reporting period.

Scale indicator24 records

Each record includes

Type, Value, Description, Source

Partnership16 partners
1Singapore Agency for Science, Technology and Research (A*STAR)
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2026-08-11
Description

Haleon and A*STAR launched a new clinical study on women's metabolic health in Asia. The study extends Haleon's scientific evidence base in the region and supports the company's VMS and self-care portfolio with clinical data.

en.prnasia.com
2Carl Radke's Soft Bar
Strategic tierMinorTypeGTM or Marketing PartnerAnnounced on2026-08-06
Description

Emergen-C partnered with Carl Radke's Soft Bar to become the 'Drink of the Summer', making everyday wellness a refreshing summer ritual. The collaboration pairs a Haleon supplement brand with a non-alcoholic beverage brand for co-marketing and consumer trial.

businesswire.com
3Soft Bar
Strategic tierMinorTypeGTM or Marketing PartnerAnnounced on2026-08-06
Description

Reported as Haleon partnering with Soft Bar for Emergen-C mocktails, extending the 'Drink of the Summer' activation to mocktail occasions.

stocktitan.net
4UEFA Medical
Strategic tierFlagshipTypeStrategic or Co-development PartnerAnnounced on2026-05-13
Description

Haleon became UEFA Medical's first Health Partner in a multi-year scientific partnership. The collaboration advances evidence-based topical pain management, recovery and athlete health across football and sport, linking Haleon's Voltaren topical portfolio with UEFA's medical programme.

haleon.com
5UEFA Champions League (UC3)
Strategic tierFlagshipTypeGTM or Marketing PartnerAnnounced on2026-03-31
Description

Voltaren, produced by Haleon, announced a two-year partnership under which its products become Official UEFA Champions League Licensed Products for the 2025/26 and 2026/27 seasons. The deal uses football audiences to keep fans moving and support topical pain relief demand.

haleon.com
6Schneider Electric
Strategic tierMinorTypeStrategic or Co-development Partner
Description

Listed among Haleon's key collaborations in its Health Inclusivity and Sustainability framework, supporting decarbonisation of pharma supply chains alongside other industry partners.

haleon.com
7Johnson Controls
Strategic tierMinorTypeStrategic or Co-development Partner
Description

Named as a key collaboration in Haleon's Health Inclusivity and Sustainability framework, linked to decarbonising pharma supply chains and energy efficiency of manufacturing operations.

haleon.com
8ZeroRoute
Strategic tierMinorTypeOthers
Description

Included in Haleon's key collaborations section for its Health Inclusivity and Sustainability strategy, contributing to value-chain resilience and supply-chain emissions initiatives.

haleon.com
9WRAP
Strategic tierMinorTypeOthers
Description

Key collaboration supporting Haleon's packaging and recycled-content sustainability goals, including making packaging recycle-ready and reducing virgin petroleum-based plastic.

haleon.com
10Consumer Goods Forum
Strategic tierMinorTypeOthers
Description

Industry body Haleon works with on sustainability and health inclusivity initiatives; Haleon's CEO Brian McNamara also serves as a Board Member of the Consumer Goods Forum.

haleon.com
11Ellen MacArthur Foundation
Strategic tierMinorTypeOthers
Description

Named in Haleon's key collaborations, supporting circular-economy and sustainable sourcing work in the Health Inclusivity and Sustainability framework.

haleon.com
12Forum for the Future
Strategic tierMinorTypeOthers
Description

Key collaboration in Haleon's Health Inclusivity and Sustainability strategy, contributing to long-term resilience and sustainability of the value chain.

haleon.com
13BSR
Strategic tierMinorTypeOthers
Description

Named in Haleon's key collaborations for social and human-rights standards across its people, suppliers and partners.

haleon.com
14Action for Sustainable Derivatives
Strategic tierMinorTypeOthers
Description

Key collaboration supporting Haleon's sustainable sourcing of ingredients and deforestation-free key materials.

haleon.com
15Energize
Strategic tierMinorTypeOthers
Description

Key collaboration listed by Haleon in the Health Inclusivity and Sustainability framework, associated with energy and emissions reduction activity across operations.

haleon.com
16CIPPA
Strategic tierMinorTypeOthers
Description

Key collaboration within Haleon's Health Inclusivity and Sustainability framework, linked to packaging and resource-efficiency programmes.

haleon.com
Recent move11 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight10 records

Each record includes

Type, Description

Peers10 records
1Kenvue
TypeDirect peer
Description

Spun out of Johnson & Johnson in 2023 as a pure-play consumer health company (Tylenol, Listerine, Neutrogena, Band-Aid), it is the closest listed structural analogue to Haleon with the same OTC/consumer-health model, pharmacy-led route to market and global brand portfolio.

2Procter & Gamble
TypeBroad incumbent
Description

Owner of Crest and Oral-B and a stated competitor for Haleon's shelf space in oral care, plus Vicks for cold/flu; it is the large diversified incumbent competing most directly with Haleon in Haleon's lead category.

3Colgate-Palmolive
TypeBroad incumbent
Description

Global oral care leader (Colgate, Total, Elmex) and the other principal toothpaste/mouthwash competitor to Haleon's Sensodyne, parodontax and Polident brands in the mass-retail channel.

4Reckitt
TypeDirect peer
Description

UK-listed consumer health company behind Dettol, Strepsils and Nurofen, combining OTC medicines, consumer health and hygiene brands sold through the same global pharmacy and retail channels as Haleon.

5Sanofi
TypeBroad incumbent
Description

Owner of consumer health brands (Vicks, children's Tylenol, allergy brands) alongside a larger prescription pharmaceutical business, so it overlaps with Haleon in OTC while retaining broader pharma exposure.

6Bayer
TypeBroad incumbent
Description

Operates a large consumer health division (Aspirin, Rennie, Clarityne) that overlaps with Haleon's pain relief and digestive health franchises, within a broader pharma, crop science and consumer health group.

7Johnson & Johnson
TypeBroad incumbent
Description

Former owner of the consumer health business now listed as Kenvue, with remaining OTC participation through brands such as Tylenol; a broad incumbent in the same self-care and pharmacy channel.

8Grifols
TypeOthers
Description

Not a branded-OTC competitor, but a relevant adjacent consumer-health/biologics participant; useful as a comparison point for consumer health companies with heavy manufacturing footprint and regulatory burden.

9Prestige Consumer Healthcare
TypeDirect peer
Description

North America-focused OTC portfolio company (Crest, Clear Eyes, Chloraseptic, Halls) built through brand acquisitions with a comparable branded consumer health route-to-market, though narrower geography and category mix.

10Church & Dwight
TypeDirect peer
Description

Owns OTC consumer health brands (First Aid, Advil competitor brands such as Advil alternatives, Orajel, Summer's Eve) sold through pharmacy and mass retail, competing with Haleon's pain relief and therapeutic skin health franchises in the same US channels.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat7 records

Each record includes

Type, Details

Key risks7 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers3 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment5 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile4 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

Integration1 record

Each record includes

Title, Type, Description, Source

AI capability4 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature6 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles33 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

Subsidiaries8 records

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds1 record

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A1 record

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment2 records

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Haleon

Consumer Health / Over-the-Counter Medicines and Personal Care Productshaleon.com

Haleon is a pure-play consumer health company selling over-the-counter medicines, oral care, supplements and skin health brands such as Sensodyne, Advil, Centrum and Voltaren to consumers across more than 170 markets, through pharmacy, retail, wholesale and digital channels.

What Haleon does

Haleon is a pure-play consumer health company created in July 2022 as a standalone listed entity following its demerger from GlaxoSmithKline, with a premium listing on the London Stock Exchange and a NYSE listing (HLN) via sponsored ADRs. It is headquartered in Weybridge, UK, employs 10,000+ people, and sells branded over-the-counter medicines, oral care products, vitamins/minerals/supplements and therapeutic skin health products across more than 170 markets organised into five regions. Its portfolio spans six global categories - Oral Health, Vitamins, Minerals and Supplements, Pain Relief, Respiratory, Digestive Health and other, and Therapeutic Skin Health - built around nine Power Brands (Sensodyne, parodontax, Polident, Centrum, Emergen-C, Caltrate, Otrivin, Theraflu, Flonase, Robitussin, Voltaren, Panadol, Advil, Excedrin, Tums, Eno, Fenistil, Zovirax and Bactroban) plus local growth brands, and reaches 1.4 billion consumers with an ambition to reach one billion more by 2030.

The technical base is a consumer-health R&D and regulatory platform rather than a software platform: decades of testing, clinical trials and real-world-evidence studies, world-class regulatory and product-licence expertise, a new c.£200m R&D facility, and 127 product innovations reported in 2024. Haleon claims leadership in therapeutic oral health, backed by brands such as Sensodyne, parodontax and Polident, and it uses clinical evidence as a marketing asset - the 2026 Nature Medicine publication based on the COSMOS trial showing Centrum Silver may slow biological ageing in older adults. Product innovation in 2026 included Excedrin Rapid Relief (relief in as little as 15 minutes), the Centrum Age Defy multivitamin for adults 35+, Panacombo dual-action tablets and the Sensodyne Clinical Repair line. On the technology side Haleon is deploying AI agents feeding a "clean core" SAP operating model across machine, energy, supply chain and customer-experience data, and it has added AI/ML-adjacent commercial analytics around algorithms, loyalty and execution; there is no public developer API or partner-facing model access.

Revenue is generated from one-time branded product sales through retail, pharmacy, wholesale and digital channels rather than recurring subscriptions; pricing is not publicly disclosed. Route-to-market is built around direct relationships with pharmacists, shopper-experience tools, in-store category-growth execution programmes and pharmacist education, supported by an extensive field sales force, with mass-retail shelf placement (Walmart, Target) contested against Procter & Gamble and Colgate-Palmolive. The company operates 25 manufacturing sites (24 certified to the Alliance for Water Stewardship Standard), reports 100% satisfactory health authority inspections in 2025, and targets £800m of gross cost savings over five years from its standalone supply chain. FY2025 revenue was £11bn; H1 2026 revenue was £5.6bn with non-GAAP EPS of 10.30p and FY 2026 guidance reaffirmed, against a stated financial algorithm of 4-6% annual organic revenue growth with high-single-digit adjusted operating profit growth at constant currency in a c.£200bn consumer healthcare market.

Haleon firmographics

Firmographics
Name
Haleon
Legal name
Haleon plc
Website
https://haleon.com
Company type
Public
Founded year
2022
Operating status
Operating
Headcount range
10,001+ employees
Short description
Haleon is a pure-play consumer health company selling over-the-counter medicines, oral care, supplements and skin health brands such as Sensodyne, Advil, Centrum and Voltaren to consumers across more than 170 markets, through pharmacy, retail, wholesale and digital channels.
Ownership category
akta.pro rank

Haleon industry classification

Industry
Product category
Consumer Health / Over-the-Counter Medicines and Personal Care Products
NAICS
Drugs and Druggists' Sundries Merchant Wholesalers (42421), Drugs and Druggists' Sundries Merchant Wholesalers (4242), Drugs and Druggists' Sundries Merchant Wholesalers (424210)
SIC
Pharmaceutical Preparations (2834)
akta.pro industry
PRIMARYCRADAMAD
Cold, Flu, Cough & Allergy Remedies (Decongestants, Antihistamines, Cough Syrups, Lozenges)
Consumer Products & Retail/Consumer Packaged Goods (CPG) Manufacturing & Brands/Health & Hygiene OTC Consumer Goods (First Aid, Oral Care, Personal Health)
SECONDARYCRADAMAF
Dermatology OTC & Skin Health (Acne Treatments, Eczema/Psoriasis OTC, Antifungals, Wart Removal)
Consumer Products & Retail/Consumer Packaged Goods (CPG) Manufacturing & Brands/Health & Hygiene OTC Consumer Goods (First Aid, Oral Care, Personal Health)
SECONDARYCRADAMAE
Digestive Health OTC (Antacids, Laxatives, Anti-diarrheals, Probiotics OTC)
Consumer Products & Retail/Consumer Packaged Goods (CPG) Manufacturing & Brands/Health & Hygiene OTC Consumer Goods (First Aid, Oral Care, Personal Health)
SECONDARYCRADAMAG
Eye, Ear & Nasal Care OTC (Eye Drops, Ear Drops/Wax Removal, Saline Sprays)
Consumer Products & Retail/Consumer Packaged Goods (CPG) Manufacturing & Brands/Health & Hygiene OTC Consumer Goods (First Aid, Oral Care, Personal Health)
SECONDARYCRADAMAJ
Sleep, Stress & Mood OTC (Sleep Aids, Melatonin OTC, Calm/Stress Relief)
Consumer Products & Retail/Consumer Packaged Goods (CPG) Manufacturing & Brands/Health & Hygiene OTC Consumer Goods (First Aid, Oral Care, Personal Health)

Keywords

  • Over-the-counter medicines
  • Consumer health brands
  • Oral care products
  • Self-care health products
  • Vitamins and supplements

Where Haleon is headquartered

Location

Headquarters

HQ city
London
HQ country
United Kingdom
HQ region
Europe

Offices31 records

Markets served

Haleon business model

Business model
GTM type
B2C
Offering type
Hardware or Manufacturing
Cost components
Supply Chain, Operations, Marketing or Sales, Technology or R&D, Personnel, Infrastructure

Revenue model

  1. Branded consumer health product sales (Oral Health, VMS, Pain Relief, Respiratory, Digestive Health, Therapeutic Skin Health): One-time sales of over-the-counter medicines, oral care products, vitamins/minerals/supplements and therapeutic skin health products through retail, pharmacy and other channels across 170+ markets. This is the core revenue engine (FY2025 revenue £11bn; H1 2026 revenue £5.6bn), driven by category leadership, brand recommendation by health professionals and innovation-led premiumisation rather than recurring subscription revenue.
  2. Distribution and route-to-market wholesale (including new rural distribution build-out): Revenue generated through selling branded products into wholesalers, pharmacy chains and mass retail, with expanded rural distribution in India (part of the £175m India investment) increasing access and volume throughput of oral health products.

Go-to-market motion4 records

Distribution channels5 records

Marketing channels9 records

Haleon product offering

Product offering

Core offering

Haleon manufactures and sells branded over-the-counter (OTC) medicines and consumer health products across six categories: Oral Health, Vitamins, Minerals and Supplements, Pain Relief, Respiratory, Digestive Health and other, and Therapeutic Skin Health. The portfolio is built around nine global Power Brands (Sensodyne, parodontax, Polident, Centrum, Emergen-C, Caltrate, Otrivin, Theraflu, Flonase, Voltaren, Panadol, Advil) plus local growth brands, sold through retail, pharmacy and wholesale channels in more than 170 markets. Haleon also operates the Haleon Health Partner digital portal for health professionals, an innovation portal and a supplier portal. FY2025 revenue was £11bn.

Product overview

Haleon is a pure-play consumer health company selling a portfolio of over-the-counter brands rather than a single software platform: it groups brands into six categories (Oral Health; Vitamins, Minerals and Supplements; Pain Relief; Respiratory; Digestive Health and other; Therapeutic Skin Health) built around nine Power Brands plus local growth brands. The Oral Health cluster is led by Sensodyne (sensitivity toothpaste/mouthwash), parodontax (gum health) and Polident (denture care), supported by Aquafresh, Biotene and Corsodyl; the VMS cluster by Centrum (multivitamins/minerals, e.g. Centrum Age Defy), Caltrate (calcium) and Emergen-C (vitamin C); Pain Relief by Panadol, Advil, Fenbid, Voltaren, Excedrin, Contac and Grand-pa; Respiratory by Otrivin, Theraflu, Flonase and Robitussin; Digestive Health by Tums, Eno, Benefiber and Alli; and Therapeutic Skin Health by Fenistil, Zovirax, Bactroban, Zovirax Duo and Chapstick/Abreva. Alongside these physical consumer brands Haleon operates related digital services and platforms, including the Haleon Health Partner portal for health professionals, an Innovation Portal, a Supplier Portal, investor Share Price Tools, the haleon.help consumer relations and adverse-event reporting service, and a Safety Data Sheets portal.

Differentiator

Problem solved

Functional benefit

Brands

  • Sensodyne: Oral health brand (toothpaste) for sensitive teeth; a leading Power Brand.
  • parodontax
  • Polident
  • Centrum
  • Emergen-C
  • Caltrate
  • Otrivin
  • Theraflu
  • Flonase
  • Robitussin
  • Voltaren
  • Panadol
  • Advil
  • Fenbid
  • Contac
  • Grand-pa
  • Excedrin
  • Benefiber
  • Tums
  • Eno
  • Fenistil
  • Zovirax
  • Bactroban

Products and services

  • Sensodyne Specialist sensitivity toothpaste and mouthwash brand positioned at the forefront of Haleon's therapeutic oral health category, including Sensodyne Repair and Clinical Repair variants and mouthwash line extensions.
  • parodontax Therapeutic gum-health toothpaste and mouthwash brand (parodontax Active Gum Health) being expanded in China with local flavours to meet rising gum-health demand.
  • Polident Brand of daily dental appliance cleaners for denture care, including overnight whitening tablet formats, within Haleon's oral health portfolio.
  • Aquafresh Oral care brand (toothpaste, toothbrushes including the 1998 flex neck brush) within Haleon's oral health portfolio.
  • Biotene Oral care brand acquired in 2008, including moisturising mouthwash for dry mouth.
  • Corsodyl Oral care brand launched as a gel and mouthwash in 1975, acquired by SmithKline Beecham in 1993.
  • Centrum Category-leading multivitamin and mineral brand available in more than 70 markets, with variants such as Centrum MEN Multi-Gummies and the Centrum Age Defy multivitamin for adults 35+.
  • Emergen-C Vitamin C immune support brand in crystals and effervescent formulations, extended through a 'Drink of the Summer' campaign and mocktail collaboration with Carl Radke's Soft Bar.
  • Caltrate Leading calcium supplement brand within Haleon's vitamins, minerals and supplements category, now with double vitamin D3 formulations.
  • Otrivin Nasal decongestant brand used to clear blocked noses, part of Haleon's cold and flu, decongestant and allergy portfolio.
  • Theraflu Multi-symptom cold and flu treatment brand addressing fever, nasal congestion and cough (e.g. Theraflu Flu Relief Max Strength).
  • Flonase Nasal allergy relief spray brand (Flonase Sensimist Allergy Relief Spray) in Haleon's respiratory health category.
  • Robitussin Cough remedy brand including long-acting cough soft chews, within Haleon's leading respiratory portfolio.
  • Voltaren Topical anti-inflammatory gel and arthritis pain gel brand (e.g. Voltaren Sport gel, Arthritis Pain Gel) used in sports, golf and UEFA Champions League licensed campaigns.
  • Panadol World-leading paracetamol-based pain relief brand (Panadol Advance 500mg) serving as a global flagship of Haleon's pain relief portfolio.
  • Advil Ibuprofen pain relief brand including liquid gels and minis formats, originating from the 1984 launch and now a core global Haleon brand.
  • Fenbid Ibuprofen pain relief brand also sold in chewable format, launched in 1983 (as Solpaflex in some markets).
  • Contac Pain and cold remedy brand in Haleon's pain relief portfolio.
  • Grand-pa Headache powder brand sold in stick-pack formats within Haleon's pain relief range.
  • Excedrin Headache relief brand (Excedrin Extra Strength) now marketed with a Rapid Relief claim of relief in as little as 15 minutes and a digital pet experience campaign.
  • Tums Antacid brand with chewy bites and tablet formats for heartburn and acid indigestion.
  • Eno Antacid brand (Eno Blue) with heritage in treating heartburn, acid indigestion and gastric discomfort.
  • Benefiber Prebiotic fibre supplement brand sold in gummy format within Haleon's digestive health portfolio.
  • Fenistil Soothing antihistamine brand (including drops) for skin allergy conditions in Haleon's therapeutic skin health category.
  • Zovirax Cold sore cream brand with duo and single-tube variants for cold sore treatment.
  • Bactroban Topical antibiotic ointment brand for bacterial skin infections.
  • Abreva Cold sore treatment brand in Haleon's therapeutic skin health category.
  • Haleon Health Partner portal Digital portal for health professionals providing clinical and consumer education resources to support recommendation of Haleon brands; it grew to 39 markets and supported over 52 million individuals in the 2025 reporting period.

Quantifiable outcome

  • 74 million+ people empowered to be more included in opportunities for better everyday health in the 2025 reporting period (1 Dec 2024-30 Nov 2025), surpassing the goal set in 2022
  • +8 more outcomes

Companies that use Haleon

Customer profile

Named customers3 records

Segments5 records

Ideal customer profiles4 records

Haleon technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Integration1 record

AI capability4 records

Feature6 records

Haleon partnerships and signals

Strategic signal

Partnerships

16 partnerships are on record, tiered core, minor and flagship.

  • Singapore Agency for Science, Technology and Research (A*STAR)coreStrategic or Co-development Partner · 11 August 2026Haleon and A*STAR launched a new clinical study on women's metabolic health in Asia. The study extends Haleon's scientific evidence base in the region and supports the company's VMS and self-care portfolio with clinical data.
  • Carl Radke's Soft BarminorGTM or Marketing Partner · 6 August 2026Emergen-C partnered with Carl Radke's Soft Bar to become the 'Drink of the Summer', making everyday wellness a refreshing summer ritual. The collaboration pairs a Haleon supplement brand with a non-alcoholic beverage brand for co-marketing and consumer trial.
  • Soft BarminorGTM or Marketing Partner · 6 August 2026Reported as Haleon partnering with Soft Bar for Emergen-C mocktails, extending the 'Drink of the Summer' activation to mocktail occasions.
  • UEFA MedicalflagshipStrategic or Co-development Partner · 13 May 2026Haleon became UEFA Medical's first Health Partner in a multi-year scientific partnership. The collaboration advances evidence-based topical pain management, recovery and athlete health across football and sport, linking Haleon's Voltaren topical portfolio with UEFA's medical programme.
  • UEFA Champions League (UC3)flagshipGTM or Marketing Partner · 31 March 2026Voltaren, produced by Haleon, announced a two-year partnership under which its products become Official UEFA Champions League Licensed Products for the 2025/26 and 2026/27 seasons. The deal uses football audiences to keep fans moving and support topical pain relief demand.
  • Schneider ElectricminorStrategic or Co-development PartnerListed among Haleon's key collaborations in its Health Inclusivity and Sustainability framework, supporting decarbonisation of pharma supply chains alongside other industry partners.
  • Johnson ControlsminorStrategic or Co-development PartnerNamed as a key collaboration in Haleon's Health Inclusivity and Sustainability framework, linked to decarbonising pharma supply chains and energy efficiency of manufacturing operations.
  • ZeroRouteminorOthersIncluded in Haleon's key collaborations section for its Health Inclusivity and Sustainability strategy, contributing to value-chain resilience and supply-chain emissions initiatives.
  • WRAPminorOthersKey collaboration supporting Haleon's packaging and recycled-content sustainability goals, including making packaging recycle-ready and reducing virgin petroleum-based plastic.
  • Consumer Goods ForumminorOthersIndustry body Haleon works with on sustainability and health inclusivity initiatives; Haleon's CEO Brian McNamara also serves as a Board Member of the Consumer Goods Forum.
  • Ellen MacArthur FoundationminorOthersNamed in Haleon's key collaborations, supporting circular-economy and sustainable sourcing work in the Health Inclusivity and Sustainability framework.
  • Forum for the FutureminorOthersKey collaboration in Haleon's Health Inclusivity and Sustainability strategy, contributing to long-term resilience and sustainability of the value chain.
  • BSRminorOthersNamed in Haleon's key collaborations for social and human-rights standards across its people, suppliers and partners.
  • Action for Sustainable DerivativesminorOthersKey collaboration supporting Haleon's sustainable sourcing of ingredients and deforestation-free key materials.
  • EnergizeminorOthersKey collaboration listed by Haleon in the Health Inclusivity and Sustainability framework, associated with energy and emissions reduction activity across operations.
  • CIPPAminorOthersKey collaboration within Haleon's Health Inclusivity and Sustainability framework, linked to packaging and resource-efficiency programmes.

Scale indicators24 records

Recent moves11 records

Expansion highlights10 records

Haleon competitors and assessment

Company assessment

Direct peers

  • Kenvue: Spun out of Johnson & Johnson in 2023 as a pure-play consumer health company (Tylenol, Listerine, Neutrogena, Band-Aid), it is the closest listed structural analogue to Haleon with the same OTC/consumer-health model, pharmacy-led route to market and global brand portfolio.
  • Reckitt: UK-listed consumer health company behind Dettol, Strepsils and Nurofen, combining OTC medicines, consumer health and hygiene brands sold through the same global pharmacy and retail channels as Haleon.
  • Prestige Consumer Healthcare: North America-focused OTC portfolio company (Crest, Clear Eyes, Chloraseptic, Halls) built through brand acquisitions with a comparable branded consumer health route-to-market, though narrower geography and category mix.
  • Church & Dwight: Owns OTC consumer health brands (First Aid, Advil competitor brands such as Advil alternatives, Orajel, Summer's Eve) sold through pharmacy and mass retail, competing with Haleon's pain relief and therapeutic skin health franchises in the same US channels.

Broad incumbents

  • Procter & Gamble: Owner of Crest and Oral-B and a stated competitor for Haleon's shelf space in oral care, plus Vicks for cold/flu; it is the large diversified incumbent competing most directly with Haleon in Haleon's lead category.
  • Colgate-Palmolive: Global oral care leader (Colgate, Total, Elmex) and the other principal toothpaste/mouthwash competitor to Haleon's Sensodyne, parodontax and Polident brands in the mass-retail channel.
  • Sanofi: Owner of consumer health brands (Vicks, children's Tylenol, allergy brands) alongside a larger prescription pharmaceutical business, so it overlaps with Haleon in OTC while retaining broader pharma exposure.
  • Bayer: Operates a large consumer health division (Aspirin, Rennie, Clarityne) that overlaps with Haleon's pain relief and digestive health franchises, within a broader pharma, crop science and consumer health group.
  • Johnson & Johnson: Former owner of the consumer health business now listed as Kenvue, with remaining OTC participation through brands such as Tylenol; a broad incumbent in the same self-care and pharmacy channel.

Others

  • Grifols: Not a branded-OTC competitor, but a relevant adjacent consumer-health/biologics participant; useful as a comparison point for consumer health companies with heavy manufacturing footprint and regulatory burden.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat7 records

Key risks7 records

Key highlights7 records

Customer concentration

Haleon social profiles

Digital presence

Haleon financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Haleon leadership team

Management profile

Number of profiles

Profiles33 records

Haleon subsidiaries and ownership

Company hierarchy

Subsidiaries8 records

Haleon funding detail

Funding detail

Funding overview

Funding rounds1 record

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Haleon M&A and investment

M&A and investment

M&A1 record

Investments2 records

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Haleon

What does Haleon do?

Haleon manufactures and sells branded over-the-counter (OTC) medicines and consumer health products across six categories: Oral Health, Vitamins, Minerals and Supplements, Pain Relief, Respiratory, Digestive Health and other, and Therapeutic Skin Health. The portfolio is built around nine global Power Brands (Sensodyne, parodontax, Polident, Centrum, Emergen-C, Caltrate, Otrivin, Theraflu, Flonase, Voltaren, Panadol, Advil) plus local growth brands, sold through retail, pharmacy and wholesale channels in more than 170 markets. Haleon also operates the Haleon Health Partner digital portal for health professionals, an innovation portal and a supplier portal. FY2025 revenue was £11bn.

Is Haleon a public or private company?

Haleon is a public company. It is classified as public and is currently operating.

When was Haleon founded?

Haleon was founded in 2022. It employs 10,001+ people.

Where is Haleon based?

Haleon is headquartered in London, United Kingdom, in the Europe region.

How does Haleon make money?

Two revenue lines are on record. Branded consumer health product sales (Oral Health, VMS, Pain Relief, Respiratory, Digestive Health, Therapeutic Skin Health) is the primary driver. The others are distribution and route-to-market wholesale (including new rural distribution build-out).

Who are Haleon's main competitors?

Direct peers on record are Kenvue, Reckitt, Prestige Consumer Healthcare and Church & Dwight. Broad incumbents are Procter & Gamble, Colgate-Palmolive, Sanofi, Bayer and Johnson & Johnson. Grifols is listed as an others.

Does Haleon have an API?

No public API is recorded for Haleon.

What industry is Haleon in?

Haleon's product category is Consumer Health / Over-the-Counter Medicines and Personal Care Products. Its primary akta.pro industry code is CRADAMAD, Cold, Flu, Cough & Allergy Remedies (Decongestants, Antihistamines, Cough Syrups, Lozenges), with a secondary code of CRADAMAF, Dermatology OTC & Skin Health (Acne Treatments, Eczema/Psoriasis OTC, Antifungals, Wart Removal). Its NAICS code is 42421 and its SIC code is 2834.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
Simply Wall StIs Haleon (LSE:HLN) Undervalued Or Fairly Priced After The Zacks Downgrade?Haleon's ADR was downgraded to a Zacks Rank #4 (Sell) on 17 November 2026, with its share price falling 1.27% in one day and 8.74% over 30 days. The stock trades at a discount to its fair value of £3.76, but respiratory weakness and slower organic growth could shift sentiment.AD HOC NEWSHaleon-Aktie: Barclays bestätigt Kaufempfehlung und 360 Pence ZielBarclays reaffirmed its buy rating on Haleon, keeping the price target at 360 pence. The rating was published on 17 November 2026, with RBC holding at 340 pence and Morgan Stanley also recommending buy. Haleon's stock traded at 4.15 euros on 18 November 2026.Yahoo3 British AI Stocks With Revenue Up To £4.7bThree UK-listed AI healthcare stocks—Renalytix, Haleon, and AstraZeneca—are profiled, with revenue up to £4.7b. Renalytix reports $3m in healthcare software revenue, Haleon generated £4.7b across EMEA and Latin America, and AstraZeneca's oncology AI partnership is tied to its late-stage pipeline. The article notes that AI-driven efficiencies could further expand margins if cost pressures ease.Simply Wall StHaleon (LSE:HLN) Stock May Be 47% Below Fair Value On Cash FlowHaleon's share price is estimated to be undervalued on cash flow, with its DCF intrinsic value above the current £3.41 price. The company generated roughly £2.5b in free cash flow over the past year, and analysts project free cash flow growth over the next decade. Bull and bear narratives diverge on whether growth credibility and margins cap upside.Seeking AlphaHaleon: If Staples Hold Up, The Stock Should Outperform (NYSE:HLN)Haleon has underperformed since its 2022 spin from GSK, delivering just over 6% annualized returns including dividends. Its forward EV/EBITDA multiple is at an all-time low, reflecting diminished growth expectations. The stock's lower price prices in disappointment, and as long as it avoids a packaged food-style margin collapse, risk/reward favors shareholders.MarketWatchHaleon falls Monday, underperforms marketHaleon PLC shares fell 2.39% to £3.31 on Monday, underperforming the FTSE 100, which rose 1.02% to 10,782.87. The stock closed 23.71% below its 52-week high of £4.34, reached on October 15th.Defense WorldBioHarvest Sciences (NASDAQ:BHST) and Haleon (NYSE:HLN) Head to Head ContrastBioHarvest Sciences and Haleon are compared on profitability, valuation, risk, and analyst ratings. Haleon has higher revenue and earnings, but BioHarvest Sciences trades at a lower P/E and has a higher potential upside. Haleon beats BioHarvest Sciences on 11 of 13 factors.